A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT04696653
- Status
- Completed
Conditions
- Diabetes Mellitus
- Dyslipidemias
- Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Comprehensive Unit Based Safety Program (CUSP) — OTHERCUSP is a quality improvement strategy developed by the Johns Hopkins University Armstrong Institute for Patient Safety and Quality that is used to improve care delivery.
Study Details
This pilot study will examine whether an implementation strategy will improve delivery of evidence-based care for cardiovascular risk factors for people with serious mental illness.
Key Dates
- Start date
- Feb 24, 2021
- Status verified
- Sep 2025
- Primary completion
- Nov 21, 2022
- Completion
- Apr 5, 2023
Study Design
- Enrollment
- 85 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Other: Comprehensive unit based safety (CUSP) intervention armCUSP is a quality improvement strategy developed by the Johns Hopkins University Armstrong Institute for Patient Safety and Quality that is used to improve care delivery.
Primary Outcome Measure
Quality Improvement Culture as Assessed by the Modified Version of the Validated Survey on Patient Safety [ Time Frame: Baseline, 12 Months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Adult Psychiatric Rehabilitation Program | Baltimore | Maryland | 21224 | - |
Find similar trials in Baltimore, MD
By condition
By specialty
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Genetic Studies of Insulin and DiabetesRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Clinical and Molecular Characteristics of Primary Aldosteronism in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona